Master Framework For Relapse or Refractory Acute Myeloid Leukemia

Clinical trial NCT06459024 · RECRUITING

Trial details

NCT number: NCT06459024
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: RECRUITING
Study type: OBSERVATIONAL

Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukemia Refractory

Start date: 2024-06-28
Primary completion: 2032-07-01
Enrollment: 4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.